Hero Background

US Pharmacy Management System Market

ID: MRFR/Pharma/11291-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Pharmacy Management System Market Research Report: Size, Share, Trend Analysis By Solution Type (Pharmacy Inventory Management System, Pharmacy Data Management System, Pharmacy Compounding Software System, Pharmacy Benefits Management System, Pharmacy Revenue Cycle Management System, Others), By Component (Software, Hardware, Services), By Deployment Mode (Web-Based, On-Premise) and By End Users (Inpatient Pharmacies, Outpatient Pharmacies) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Retail Pharmacy
      2. 4.1.2 Hospital Pharmacy
      3. 4.1.3 Clinical Pharmacy
      4. 4.1.4 Long-term Care Pharmacy
    2. 4.2 Healthcare, BY Deployment Type (USD Billion)
      1. 4.2.1 On-premise
      2. 4.2.2 Cloud-based
      3. 4.2.3 Web-based
    3. 4.3 Healthcare, BY End User (USD Billion)
      1. 4.3.1 Pharmacists
      2. 4.3.2 Pharmacy Technicians
      3. 4.3.3 Healthcare Providers
      4. 4.3.4 Patients
    4. 4.4 Healthcare, BY Features (USD Billion)
      1. 4.4.1 Inventory Management
      2. 4.4.2 Prescription Management
      3. 4.4.3 Billing and Invoicing
      4. 4.4.4 Reporting and Analytics
    5. 4.5 Healthcare, BY Integration (USD Billion)
      1. 4.5.1 Electronic Health Records
      2. 4.5.2 Insurance Systems
      3. 4.5.3 Supply Chain Management
      4. 4.5.4 Laboratory Information Systems
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 McKesson Corporation (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 CVS Health Corporation (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Walgreens Boots Alliance (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cardinal Health, Inc. (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 OptumRx (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Cerner Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Epic Systems Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Allscripts Healthcare Solutions, Inc. (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY APPLICATION
    3. 6.3 US MARKET ANALYSIS BY DEPLOYMENT TYPE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY FEATURES
    6. 6.6 US MARKET ANALYSIS BY INTEGRATION
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    15. 6.15 HEALTHCARE, BY DEPLOYMENT TYPE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY DEPLOYMENT TYPE, 2024 TO 2035 (USD Billion)
    17. 6.17 HEALTHCARE, BY END USER, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    19. 6.19 HEALTHCARE, BY FEATURES, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY FEATURES, 2024 TO 2035 (USD Billion)
    21. 6.21 HEALTHCARE, BY INTEGRATION, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY INTEGRATION, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY DEPLOYMENT TYPE, 2026-2035 (USD Billion)
      3. 7.2.3 BY END USER, 2026-2035 (USD Billion)
      4. 7.2.4 BY FEATURES, 2026-2035 (USD Billion)
      5. 7.2.5 BY INTEGRATION, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Clinical Pharmacy
  • Long-term Care Pharmacy

Healthcare By Deployment Type (USD Billion, 2026-2035)

  • On-premise
  • Cloud-based
  • Web-based

Healthcare By End User (USD Billion, 2026-2035)

  • Pharmacists
  • Pharmacy Technicians
  • Healthcare Providers
  • Patients

Healthcare By Features (USD Billion, 2026-2035)

  • Inventory Management
  • Prescription Management
  • Billing and Invoicing
  • Reporting and Analytics

Healthcare By Integration (USD Billion, 2026-2035)

  • Electronic Health Records
  • Insurance Systems
  • Supply Chain Management
  • Laboratory Information Systems